Test filters | DNDi

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

In the media

15 Jul 2026

Dengue outbreak complicates Bangladesh measles crisis response

The Telegraph

Press releases

13 Jul 2026

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security

Press releases

13 Jul 2026

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Scientific articles

9 Jul 2026

Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring

PLOS Neglected Tropical Diseases

In the media

9 Jul 2026

Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy

The Indian Express

In the media

8 Jul 2026

No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials

The Print

In the media

8 Jul 2026

How Scientists Can Revive Global Health Drug Development

Deccan Herald

Press Releases Translations

8 Jul 2026

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Press Releases Translations

8 Jul 2026

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

Press releases

8 Jul 2026

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Press Releases Translations

8 Jul 2026

ไทย บราซิล และ มาเลเซีย เตรียมเริ่มการศึกษาวิจัยทางคลินิก เพื่อทดสอบยารักษาไข้เลือดออกชนิดใหม่ที่พัฒนาโดยสถาบันเซรุ่มแห่งอินเดีย

Scientific articles

7 Jul 2026

Integrating molecular similarity and alphafold-based structural alignment for target discovery in trypanosoma cruzi

Pharmaceuticals

Stories

30 Jun 2026

Cryptococcal meningitis: Africa’s neglected HIV killer

Publications

30 Jun 2026

2025 DNDi Financial Report

Publications

29 Jun 2026

Advancing global health innovation through Europe-Africa collaboration

News

29 Jun 2026

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Dengue outbreak complicates Bangladesh measles crisis response

DNDi welcomes continued GHIT support for collaboration on dengue and Zika virus drug discovery with Eisai and new partner, the Japan Institute for Health Security

DNDi welcomes GHIT support to advance novel oral drug candidate for leishmaniasis, accelerating progress towards elimination goals

Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring

Serum Institute of India ties up with DNDi for Phase III trial of dengue therapy

No medicine for dengue yet, Serum Institute’s new treatment is headed for global trials

How Scientists Can Revive Global Health Drug Development

Brasil, Malásia e Tailândia estão prestes a iniciar ensaio clínico para testar tratamento promissor contra a dengue desenvolvido pelo Instituto Serum da Índia

Brasil, Malasia y Tailandia están a punto de iniciar ensayos clínicos para probar un prometedor tratamiento contra el dengue desarrollado por el Serum Institute of India

Brazil, Malaysia, and Thailand set to start global clinical trial to test promising dengue treatment developed by Serum Institute of India

Integrating molecular similarity and alphafold-based structural alignment for target discovery in trypanosoma cruzi

Cryptococcal meningitis: Africa’s neglected HIV killer

2025 DNDi Financial Report

Advancing global health innovation through Europe-Africa collaboration

Eric Easom, Dr Marcus Lacerda, and Mathieu Lamiaux join the DNDi Board of Directors

Learn more

Get in touch

Support us

Work with us